Membrane rafts play a crucial role in receptor activator of nuclear factor κB signaling and osteoclast function

被引:107
|
作者
Ha, H
Kwak, HB
Lee, SK
Na, DS
Rudd, CE
Lee, ZH
Kim, HH
机构
[1] Chosun Univ, Sch Dent, Gwangju 501759, South Korea
[2] Chosun Univ, Natl Res Lab Bone Metab, Gwangju 501759, South Korea
[3] Chosun Univ, Res Ctr Proteineous Mat, Gwangju 501759, South Korea
[4] Univ Ulsan, Coll Med, Dept Biochem, Seoul 138736, South Korea
[5] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Dept Haematol, London W12 ONN, England
关键词
D O I
10.1074/jbc.M212626200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Membrane lipid rafts play a key role in immune cell activation by recruiting and excluding specific signaling components of immune cell surface receptors upon the receptor engagement. Despite this, the role of these microdomains in the regulation of osteoclasts as controlled by receptor activator of nuclear factor kappaB ( RANK) has yet to be established. In this study, we demonstrate that the raft microdomain expression plays an essential role in osteoclast function and differentiation. Expression of raft component flotillin greatly increased during osteoclast differentiation, whereas engagement of RANK induced the translocation of tumor necrosis factor receptor-associated factor 6 to rafts where Src was constitutively resident. Disruption of rafts blocked TRAF6 translocation and Akt activation by RANK ligand in osteoclasts and further reduced the survival of osteoclasts. Actin ring formation and bone resorption by osteoclasts were also found to require the integrity of rafts. Our observations demonstrate for the first time that RANK-mediated signaling and osteoclast function are critically dependent on the expression and integrity of raft membrane microdomains.
引用
收藏
页码:18573 / 18580
页数:8
相关论文
共 50 条
  • [1] Membrane rafts are crucial for osteoclast function
    Kim, HH
    Lee, SK
    Lee, ZH
    BONE, 2003, 32 (05) : S158 - S159
  • [2] Receptor activator of nuclear factor-κB ligand activates nuclear factor-κB in osteoclast precursors
    Wei, S
    Teitelbaum, SL
    Wang, MWH
    Ross, FP
    ENDOCRINOLOGY, 2001, 142 (03) : 1290 - 1295
  • [3] Miconazole inhibits receptor activator of nuclear factor-κB ligand-mediated osteoclast formation and function
    Zheng, Ting
    Wang, Xin
    Yim, Mijung
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 737 : 185 - 193
  • [4] Dimer formation of receptor activator of nuclear factor κB induces incomplete osteoclast formation
    Iwamoto, K
    Miyamoto, T
    Sawatani, Y
    Hosogane, N
    Hamaguchi, I
    Takami, M
    Nomiyama, K
    Takagi, K
    Suda, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 325 (01) : 229 - 234
  • [5] The osteoprotegerin/receptor activator of nuclear factor κB/receptor activator of nuclear factor κB ligand system in cartilage
    Komuro, H
    Olee, T
    Kühn, K
    Quach, J
    Brinson, DC
    Shikhman, A
    Valbracht, J
    Creighton-Achermann, L
    Lotz, M
    ARTHRITIS AND RHEUMATISM, 2001, 44 (12): : 2768 - 2776
  • [6] Serum levels of soluble receptor activator for nuclear factor kB ligand play a crucial role in the association of osteoprotegerin with coronary artery disease
    Zhou, Shaoqiong
    Wen, Hui
    Wang, Bin
    Guan, Siming
    Fang, Xin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 28 (02)
  • [7] Updates on the role of receptor activator of nuclear factor κB/receptor activator of nuclear factor κB ligand/osteoprotegerin pathway in breast cancer risk and treatment
    Bayer, Christian M.
    Beckmann, Matthias W.
    Fasching, Peter A.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2017, 29 (01) : 4 - 11
  • [8] Histamine stimulates production of osteoclast differentiation factor/receptor activator of nuclear factor-κB ligand by osteoblasts
    Deyama, Y
    Kikuiri, T
    Ohnishi, G
    Feng, YG
    Takeyama, S
    Hatta, M
    Yoshimura, Y
    Suzuki, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 298 (02) : 240 - 246
  • [9] Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease
    Pacifico, Lucia
    Andreoli, Gian Marco
    D'Avanzo, Miriam
    De Mitri, Delia
    Pierimarchi, Pasquale
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (19) : 2073 - 2082
  • [10] Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease
    Lucia Pacifico
    Gian Marco Andreoli
    Miriam D'Avanzo
    Delia De Mitri
    Pasquale Pierimarchi
    World Journal of Gastroenterology, 2018, 24 (19) : 2073 - 2082